On ECHEMI
Home > Drugs > Lamotrigine Registered Holders
Lamotrigine structure

Lamotrigine structure

Lamotrigine

Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channelTarget: Sodium ChannelLamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1]. In rat cerebral cortex tissue incubated with veratrine 10 mg/L, lamotrigine is twice as potent in inhibiting the release of glutamate and aspartate (ED 50 = 5.38 mg/L for

Find 61 Related Holders

Zhejiang Supor Pharmaceuticals Co., Ltd.
European Union European Union

API Registration Country

API Active
COHANCE LIFESCIENCES LIMITED
European Union European Union

API Registration Country

API Active
TARO PHARMACEUTICAL INDUSTRIES LTD
United States United States

API Registration Country

API Active
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
United States United States

API Registration Country

API Active
Unichem Laboratories Ltd
United States United States

API Registration Country

API Active
SYNTHEXIM CALAIRE CHIMIE
United States United States

API Registration Country

API Active
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
PHARMACEUTICAL WORKS POLPHARMA S.A.
European Union European Union

API Registration Country

API Active
APOTEX PHARMACHEM INDIA PVT LTD
United States United States

API Registration Country

API Inactive
ALKEM LABORATORIES LTD
Brazil Brazil

API Registration Country

API Inactive
  • Country:

    Brazil Brazil
  • Address:

    ALKEM HOUSE, SENAPATI BAPAT MARG, EXTERIOR - EX
Recommended Suppliers of Lamotrigine
View 138 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.